Quest Diagnostics (DGX) has issued an announcement.
Quest Diagnostics Incorporated and its subsidiary have agreed to purchase all shares of LifeLabs and partnership interests of BPC Lab Finance LP for a deal valued at around 1.35 billion Canadian Dollars, which includes net debt. The transaction, which is guaranteed by Quest Diagnostics, is subject to customary adjustments and regulatory approvals, including clearances under Canadian competition and investment laws. If successful, the acquisition will enhance Quest’s position in the Canadian diagnostic information and digital health market, with the deal expected to close by the end of the year.
See more data about DGX stock on TipRanks’ Stock Analysis page.
